+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Immunochemicals Market by Product (Antibodies, Cytokines & Chemokines, Immunoglobulins), Source (Animal-Derived, Synthetic), Application, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 184 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5889477
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Immunochemicals Market size was estimated at USD 2.92 billion in 2023, USD 3.12 billion in 2024, and is expected to grow at a CAGR of 7.19% to reach USD 4.75 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Immunochemicals Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Immunochemicals Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Immunochemicals Market, highlighting leading vendors and their innovative profiles. These include Abbiotec, Inc., Abcam PLC, Active Motif Incorporated, Agilent Technologies, Inc., AMS Biotechnology (Europe) Limited., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biocare Medical, LLC, BioGenex Laboratories, Biosynth Laboratories, BMA Biomedicals, Cayman Chemical, Cell Signaling Technology, Inc., Creative Diagnostics, Danahar Corporation, Elabscience Biotechnology Inc., F. Hoffmann-La Roche Ltd, Fortis Life Sciences, GE Healthcare, Genemed Biotechnologies, Inc., GenScript Biotech Corporation, Merck KGaA, Miltenyi Biotech, MyBioSource, Origene Technologies Inc., PerkinElmer, Inc., Rockland Immunochemicals, Inc., Santa Cruz Biotechnology, Specifica Inc., and Thermo Fisher Scientific Inc.

Market Segmentation & Coverage

This research report categorizes the Immunochemicals Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Antibodies
    • Cytokines & Chemokines
    • Immunoglobulins
  • Source
    • Animal-Derived
    • Synthetic
  • Application
    • Autoimmune Disease
    • Infectious Disease
    • Neurology
    • Oncology
  • End-User
    • Biotechnology & Pharmaceutical Companies
    • Clinical Laboratories
    • Contract Research Organizations
    • Forensic Organizations
    • Research & Academic Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Immunochemicals Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Immunochemicals Market?
  3. What are the technology trends and regulatory frameworks in the Immunochemicals Market?
  4. What is the market share of the leading vendors in the Immunochemicals Market?
  5. Which modes and strategic moves are suitable for entering the Immunochemicals Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Immunochemicals Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing drug discovery and development activities worldwide
5.1.1.2. Government support for immunochemistry, genomics, and proteomics research
5.1.1.3. Use of immunochemical techniques for early disease detection and diagnosis
5.1.2. Restraints
5.1.2.1. Risk of cross-contamination and possibilities of false positives in test kits
5.1.3. Opportunities
5.1.3.1. Rise of advanced formulations of immunochemical for research
5.1.3.2. Adoption of nanotechnology to develop advanced clinical diagnostic test kits
5.1.4. Challenges
5.1.4.1. Strict regulatory guidelines regarding the production and use of immunochemical
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Immunochemicals Market, by Product
6.1. Introduction
6.2. Antibodies
6.3. Cytokines & Chemokines
6.4. Immunoglobulins
7. Immunochemicals Market, by Source
7.1. Introduction
7.2. Animal-Derived
7.3. Synthetic
8. Immunochemicals Market, by Application
8.1. Introduction
8.2. Autoimmune Disease
8.3. Infectious Disease
8.4. Neurology
8.5. Oncology
9. Immunochemicals Market, by End-User
9.1. Introduction
9.2. Biotechnology & Pharmaceutical Companies
9.3. Clinical Laboratories
9.4. Contract Research Organizations
9.5. Forensic Organizations
9.6. Research & Academic Institutes
10. Americas Immunochemicals Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Immunochemicals Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Immunochemicals Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abbiotec, Inc.
14.1.2. Abcam PLC
14.1.3. Active Motif Incorporated
14.1.4. Agilent Technologies, Inc.
14.1.5. AMS Biotechnology (Europe) Limited.
14.1.6. Becton, Dickinson and Company
14.1.7. Bio-Rad Laboratories, Inc.
14.1.8. Bio-Techne Corporation
14.1.9. Biocare Medical, LLC
14.1.10. BioGenex Laboratories
14.1.11. Biosynth Laboratories
14.1.12. BMA Biomedicals
14.1.13. Cayman Chemical
14.1.14. Cell Signaling Technology, Inc.
14.1.15. Creative Diagnostics
14.1.16. Danahar Corporation
14.1.17. Elabscience Biotechnology Inc.
14.1.18. F. Hoffmann-La Roche Ltd
14.1.19. Fortis Life Sciences
14.1.20. GE Healthcare
14.1.21. Genemed Biotechnologies, Inc.
14.1.22. GenScript Biotech Corporation
14.1.23. Merck KGaA
14.1.24. Miltenyi Biotech
14.1.25. MyBioSource
14.1.26. Origene Technologies Inc.
14.1.27. PerkinElmer, Inc.
14.1.28. Rockland Immunochemicals, Inc.
14.1.29. Santa Cruz Biotechnology
14.1.30. Specifica Inc.
14.1.31. Thermo Fisher Scientific Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. IMMUNOCHEMICALS MARKET RESEARCH PROCESS
FIGURE 2. IMMUNOCHEMICALS MARKET SIZE, 2023 VS 2030
FIGURE 3. IMMUNOCHEMICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IMMUNOCHEMICALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. IMMUNOCHEMICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IMMUNOCHEMICALS MARKET DYNAMICS
FIGURE 7. IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 10. IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. IMMUNOCHEMICALS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. IMMUNOCHEMICALS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. IMMUNOCHEMICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. IMMUNOCHEMICALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNOCHEMICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. IMMUNOCHEMICALS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. IMMUNOCHEMICALS MARKET SIZE, BY CYTOKINES & CHEMOKINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. IMMUNOCHEMICALS MARKET SIZE, BY IMMUNOGLOBULINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 10. IMMUNOCHEMICALS MARKET SIZE, BY ANIMAL-DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. IMMUNOCHEMICALS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. IMMUNOCHEMICALS MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. IMMUNOCHEMICALS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. IMMUNOCHEMICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. IMMUNOCHEMICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. IMMUNOCHEMICALS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. IMMUNOCHEMICALS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. IMMUNOCHEMICALS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. IMMUNOCHEMICALS MARKET SIZE, BY FORENSIC ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. IMMUNOCHEMICALS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. CANADA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. CANADA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 38. CANADA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. CANADA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 42. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. MEXICO IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES IMMUNOCHEMICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. CHINA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. CHINA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 60. CHINA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. CHINA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. INDIA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. INDIA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 64. INDIA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. INDIA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. JAPAN IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 71. JAPAN IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 72. JAPAN IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. JAPAN IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. THAILAND IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. THAILAND IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 96. THAILAND IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. THAILAND IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA IMMUNOCHEMICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 107. DENMARK IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. DENMARK IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 109. DENMARK IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. DENMARK IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. EGYPT IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. EGYPT IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 113. EGYPT IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. EGYPT IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. FINLAND IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. FINLAND IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 117. FINLAND IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. FINLAND IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 121. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. FRANCE IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 125. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. GERMANY IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. ITALY IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. ITALY IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 133. ITALY IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. ITALY IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. NORWAY IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. NORWAY IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 145. NORWAY IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. NORWAY IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. POLAND IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. POLAND IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 149. POLAND IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. POLAND IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. QATAR IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. QATAR IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 153. QATAR IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. QATAR IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 169. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SPAIN IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. TURKEY IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. TURKEY IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 181. TURKEY IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. TURKEY IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM IMMUNOCHEMICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. IMMUNOCHEMICALS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 192. IMMUNOCHEMICALS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 193. IMMUNOCHEMICALS MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbiotec, Inc.
  • Abcam PLC
  • Active Motif Incorporated
  • Agilent Technologies, Inc.
  • AMS Biotechnology (Europe) Limited.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biocare Medical, LLC
  • BioGenex Laboratories
  • Biosynth Laboratories
  • BMA Biomedicals
  • Cayman Chemical
  • Cell Signaling Technology, Inc.
  • Creative Diagnostics
  • Danahar Corporation
  • Elabscience Biotechnology Inc.
  • F. Hoffmann-La Roche Ltd
  • Fortis Life Sciences
  • GE Healthcare
  • Genemed Biotechnologies, Inc.
  • GenScript Biotech Corporation
  • Merck KGaA
  • Miltenyi Biotech
  • MyBioSource
  • Origene Technologies Inc.
  • PerkinElmer, Inc.
  • Rockland Immunochemicals, Inc.
  • Santa Cruz Biotechnology
  • Specifica Inc.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages184
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.12 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.75 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal

Related Topics

Related Reports

Immunochemicals - Global Strategic Business Report - Product Image

Immunochemicals - Global Strategic Business Report

  • Report
  • 312 Pages
  • Global
From
Global Neuroscience Antibodies and Assays Market 2024-2028 - Product Image

Global Neuroscience Antibodies and Assays Market 2024-2028

  • Report
  • 162 Pages
  • Global
From
Neuroscience Antibodies and Assays - Global Strategic Business Report - Product Image

Neuroscience Antibodies and Assays - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Polyclonal Antibodies Global Market Report 2024 - Product Image

Polyclonal Antibodies Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Global Market Report 2024 - Product Image

Mammalian Polyclonal Immunoglobulin G (IgG) Antibody Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From

About the Market

The Immunochemicals market is a subset of the Immune Disorders Drugs market, which focuses on the development of treatments for diseases related to the immune system. Immunochemicals are a type of drug that modulate the immune system, either by stimulating or suppressing it. These drugs are used to treat a variety of conditions, including autoimmune diseases, allergies, and cancer. Immunochemicals can be administered orally, intravenously, or topically, depending on the condition being treated. Immunochemicals are often used in combination with other treatments, such as chemotherapy or radiation therapy, to maximize the effectiveness of the treatment. Additionally, immunochemicals can be used to reduce the side effects of other treatments, such as reducing inflammation or suppressing the immune system. Some companies in the Immunochemicals market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.